Park Soo-Yong, Yun Yang H, Park Bum-Joon, Seo Hyung-Il, Chung Ildoo
Department of Polymer Science and Engineering, Pusan National University, Busan 46241, Korea.
Department of Biomedical Engineering, College of Engineering, The University of Akron, Akron, OH 44325, USA.
Pharmaceuticals (Basel). 2021 Dec 24;15(1):17. doi: 10.3390/ph15010017.
Gene therapy is a suitable alternative to chemotherapy due to the complications of drug resistance and toxicity of drugs, and is also known to reduce the occurrence of cellular mutation through the use of gene carriers. In this study, gene carrier nanoparticles with minimal toxicity and high transfection efficiency were fabricated from a biocompatible and biodegradable polymer, l-tyrosine polyurethane (LTU), which was polymerized from presynthesized desaminotyrosyl tyrosine hexyl ester (DTH) and polyethylene glycol (PEG), by using double emulsion and solvent evaporation techniques, resulting in the formation of porous nanoparticles, and then used to evaluate their potential biological activities through molecular controlled release and transfection studies. To assess cellular uptake and transfection efficiency, two model drugs, fluorescently labeled bovine serum albumin (FITC-BSA) and plasmid DNA-linear polyethylenimine (LPEI) complex, were successfully encapsulated in nanoparticles, and their transfection properties and cytotoxicities were evaluated in LX2 as a normal cell and in HepG2 and MCF7 as cancer cells. The morphology and average diameter of the LTU nanoparticles were confirmed using light microscopy, transmission electron microscopy, and dynamic light scattering, while confocal microscopy was used to validate the cellular uptake of FITC-BSA-encapsulated LTU nanoparticles. Moreover, the successful cellular uptake of LTU nanoparticles encapsulated with pDNA-LPEI and the high transfection efficiency, confirmed by gel electrophoresis and X-gal assay transfection, indicated that LTU nanoparticles had excellent cell adsorption ability, facilitated gene encapsulation, and showed the sustained release tendency of genes through transfection experiments, with an optimal concentration ratio of pDNA and LPEI of 1:10. All the above characteristics are ideal for gene carriers designed to transport and release drugs into the cytoplasm, thus facilitating effective gene therapy.
由于耐药性和药物毒性等并发症,基因治疗是化疗的合适替代方案,并且已知通过使用基因载体可减少细胞突变的发生。在本研究中,采用双乳液和溶剂蒸发技术,由生物相容性和可生物降解的聚合物L-酪氨酸聚氨酯(LTU)制备了具有最小毒性和高转染效率的基因载体纳米颗粒,该聚合物由预合成的脱氨基酪氨酸己酯(DTH)和聚乙二醇(PEG)聚合而成,形成了多孔纳米颗粒,然后通过分子控制释放和转染研究来评估其潜在的生物活性。为了评估细胞摄取和转染效率,将两种模型药物,即荧光标记的牛血清白蛋白(FITC-BSA)和质粒DNA-线性聚乙烯亚胺(LPEI)复合物成功封装在纳米颗粒中,并在作为正常细胞的LX2以及作为癌细胞的HepG2和MCF7中评估了它们的转染特性和细胞毒性。使用光学显微镜、透射电子显微镜和动态光散射来确认LTU纳米颗粒的形态和平均直径,而共聚焦显微镜用于验证FITC-BSA封装的LTU纳米颗粒的细胞摄取。此外,通过凝胶电泳和X-gal分析转染证实,成功摄取了pDNA-LPEI封装的LTU纳米颗粒且转染效率高,这表明LTU纳米颗粒具有优异的细胞吸附能力,有助于基因封装,并且通过转染实验显示出基因的持续释放趋势,pDNA和LPEI的最佳浓度比为1:10。上述所有特性对于设计用于将药物运输并释放到细胞质中的基因载体来说都是理想的,从而有助于有效的基因治疗。